Filter
4388
Filtered Results: 4388
Text search:
drug
therapy
Featured
Recommendations
404
New Publications
1135
Language
Document type
No document type
2797
Studies & Reports
590
Guidelines
572
Manuals
161
Strategic & Response Plan
95
Fact sheets
70
Training Material
51
Situation Updates
20
Infographics
13
Resource Platforms
9
Brochures
6
Online Courses
3
App
1
Countries / Regions
India
290
Kenya
124
Global
119
South Africa
114
Uganda
98
Ethiopia
97
Western and Central Europe
94
Nigeria
82
Tanzania
79
Nepal
77
Zambia
76
Sierra Leone
62
Malawi
62
Africa
59
Eastern Europe
58
Liberia
55
Ukraine
53
Ghana
52
Latin America and the Carribbean
52
Rwanda
50
Myanmar / Burma
50
Bangladesh
41
Namibia
41
Zimbabwe
38
Russia
37
Asia
36
Indonesia
35
Lesotho
33
Philippines
32
Cambodia
28
South–East Asia Region
23
Botswana
20
Senegal
18
Syria
17
Germany
17
Eswatini/ Swaziland
16
East and Southern Africa
15
Burkina Faso
14
Mozambique
14
USA
13
West and Central Africa
13
Middle East and North Africa
13
Cameroon
11
Albania
11
Brazil
11
Tajikistan
10
Colombia
10
Haiti
10
Congo, Democratic Republic of
10
South Sudan
10
Eastern Europe and Central Asia
9
Venezuela
8
Thailand
7
Sudan
7
Pakistan
7
Benin
6
Western Pacific Region
6
Argentina
6
Georgia
6
China
5
Afghanistan
5
Peru
5
Armenia
5
Iraq
5
North Macedonia
4
Guinea
4
Paraguay
4
United Kingdom
4
Spain
4
Bolivia
4
Vietnam
4
Moldova
4
Yemen
4
Bhutan
4
Timor Leste/ East Timor
3
Laos
3
Estonia
3
Jordan
3
Jamaica
3
Sri Lanka
3
Somalia
3
Switzerland
2
Turkey
2
Kazakhstan
2
Iran
2
Canada
2
Fiji
2
Kyrgyzstan
2
Saudi Arabia
2
North America
2
Gabon
2
Southern Africa
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Angola
2
North Korea
1
Mexico
1
Serbia
1
Australia
1
Gambia
1
Chile
1
Singapore
1
Uzbekistan
1
Malaysia
1
Austria
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Hungary
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1673
Clinical Guidelines
469
Public Health
202
Women & Child Health
152
Capacity Building
60
Key Resources
56
Pharmacy & Technologies
47
Toolboxes
HIV
642
TB
481
Mental Health
441
AMR
224
COVID-19
150
Pharmacy
150
NTDs
143
NCDs
105
Caregiver
78
Rapid Response
57
Ebola
55
Refugee
46
Conflict
42
Disability
41
Planetary Health
29
Global Health Education
26
Polio
16
Health Financing Toolbox
15
Cholera
13
Specific Hazards
11
Natural Hazards
10
Zika
9
Social Ethics
6
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
Biodiversity and healthy natural ecosystems, including protected areas in and around cities, provide ecosystem benefits and services that support human health, including reducing flood risk, filtering air pollutants, and providing a reliable supply of clean drinking water. These services help to red...
Rev Panam Salud Publica. 2021;45:e74.
Some characteristics of patients and healthcare providers influence treatment success in MDR-TB cases. Physicians’ and nurses’ knowledge about MDR-TB must be improved, and follow-up of MDR-TB patients who are living with HIV and of those affiliated with the...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
El grupo de Farmacovigilancia de la red Panamericana para la Armonización Farmacéutica (PARF) de la Organización Panamericana de la Salud (OPS), ha desarrollado este documento desde la visión OPS/OMS, considerando que la farmacovigilancia es un componente esencial de los programas de salud públ...
Serie: Documentos Técnico
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
